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Abstract
Introduction:
Postoperative nausea and vomiting (PONV) is a 
major concern for patients having surgery under 
general anesthesia as it causes subjective distress 
along with increased complications and delays 
in discharge from the hospital. Aromatherapy 
represents a complementary and alternative therapy 
for the management of PONV.
Purpose:
The objective of this study was to examine the 
effectiveness of aromatherapy (QueaseEASE®, 
Soothing Scents, Inc) on postoperative nausea and 
vomiting in same-day surgery patients.
Methods:
This was a quasi-experimental study without a 
control group. The experimental group (n = 98) 
received QueaseEASE® essential oil inhalation. 
The level of postoperative nausea and vomiting was 
measured using a standard 0-10 scale up to 24 
hours after surgery.  Nausea severity was measured 
first at onset of nausea and again 30 minutes after 
aromatherapy administration. Data was collected via 
telephone calls within 2-3 days of surgery.
Results:
In total, 27 patients (27.6%) experienced PONV 
and reported nausea severity scores that showed 
QueaseEASE® helped to decrease their nausea.  
Thirty minutes after use, the average improvement 
in nausea scores was 4.94 ± 2.56 (95% CI 3.98 to 
5.91) with an average time to relief of less than 1 
minute in 74.1% of patients.
Conclusions:
Aromatherapy was favorably received by most 
patients and represents an effective treatment option 
for postoperative nausea.
Introduction
Nausea and vomiting are frequent complications of anesthesia 
post-operatively. There is an increased prevalence of 
postoperative nausea and vomiting (PONV) in patients undergoing 
mastectomies, intra-abdominal, gynecologic, and ear-nose-throat 
(ENT) surgeries. Many injectable and enteral medications are 
available for the prevention and treatment of PONV, each with 
the potential for side effects. Utilization of medications requires a 
provider order, which has the potential to delay initiation of therapy. 
The use of aromatherapy via inhalation for the treatment of 
PONV has been shown to eliminate nausea in up to 85% of 
patients. Patients have reported perceived effectiveness and 
favorable improvement with the use of aromatherapy for post-
operative nausea. Aromatherapy products have been shown to 
be well tolerated with no adverse effects, drug interactions, or 
contraindications.
The aim of this study is to determine the effectiveness of 
QueaseEASE® aromatherapy pods in the treatment of PONV in 
patients undergoing same-day hysterectomies, and intra-abdominal 
and ear-nose-throat (ENT) surgeries.
Discussion
Prior to the initiation of the project, there was evidence that 
aromatherapy was a viable option in regards to reducing post-
operative nausea and vomiting. The project sought out to see if 
these results could be reproduced amongst same day surgery 
candidates. The results produced were promising, but had 
limitations. Previous projects indicated that decreases in nausea 
after administration of aromatherapy greater than or equal to 
5 units were significant. Our average decrease in nausea was 
as a 4.94 ± 2.56. The value is within parameters of significant 
improvement when the upper limits of standard deviation are 
included, however, there are still areas where the project could 
be improved. The project had limitations associated with the time 
parameters of the study and population that was selected. A longer 
time period to collect data could have lead to better selection of 
patients that fit a certain risk group that would have been better 
able assess the effectiveness of the pods.
Conclusion
Overall the project supports the aromatic therapy implementation in 
the setting of same day surgery candidates. However, more data is 
needed to provide a recommendation for mass distribution. Further 
analysis, with special considerations in the areas of diversity of 
surgical procedures are needed.
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Methods and Materials
We distributed 100 QueaseEASE® pods to patients scheduled 
for same-day mastectomies, hysterectomies, intra-abdominal or 
ENT surgeries. Informed consent was obtained preoperatively. Up 
to 24 hours after recovery, patients were instructed to document 
their episodes of nausea, severity at onset and severity 30 minutes 
after pod use. The severity of nausea was recorded using a 
scale (0-10) where zero indicates no nausea and ten indicates 
unbearable nausea.  Use of traditional antiemetic medications 
was not excluded pursuant to individual provider practice. Data for 
concomitant antiemetic medication use, smoking status, patient 
age, sex, BMI, and previous history of PONV or motion sickness 
was also recorded.
Data was collected in the form of patient phone call interviews 2-3 
days after discharge.  Team members followed a script asking 
questions following up about the patient’s experience with using 
QueaseEASE®.
Results
Between February 18, 2019 and April 1, 2019, 98 patients were enrolled from Geisinger Medical 
Center's Post-Anesthesia Care Unit (PACU) to trial QueaseEASE® as part of their post-operative 
nausea and vomiting (PONV) experience. Of these 98 patients, 27 patients (27.6%) were lost to 
follow up.  Another 40 patients (40.8%) did not experience any PONV.  One patient reported that 
QueaseEASE® did not improve her PONV at all.  Another 3 patients did not report any nausea 
severity ratings, but expressed that when they did use the product, their nausea severity decreased in 
less than 5 minutes. 
 In total, 27 patients (27.6%) experienced PONV and reported nausea severity scores that showed 
QueaseEASE® helped to decrease their nausea.  There were fewer men (22.2%) and more 
Caucasian (96.3%) patients.  The most common surgery was abdominal (59.3%), which consisted of 
hysterectomies, laparoscopies, cholecystectomies, and hernia repairs.  There were 16 patients (59.3%) 
who had at least one risk factor for PONV, and no patient had all three investigated risk factors.
 Of the patients who used the pod, 26 patients (90.0%) used QueaseEASE® as their first-line PONV 
therapy.  Thirty minutes after using QueaseEASE®, the average improvement in nausea scores (on 
a scale of 1 to 10) was 4.94 ± 2.56 (95% CI 3.98 to 5.91) with an average time to relief of less than 1 
minute in 74.1% of patients.  Nausea severity was decreased similarly regardless of surgery type.
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